IQ EQ Fund Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.5M Sell
284,589
-86,963
-23% -$3.9M 1.03% 24
2025
Q4
$11.8M Buy
371,552
+105,701
+40% +$3.3M 0.81% 33
2025
Q3
$7.48M Buy
265,851
+126,260
+90% +$3.82M 0.51% 61
2025
Q2
$5.14M Buy
139,591
+91,546
+191% +$3.16M 0.46% 72
2025
Q1
$1.89M Buy
48,045
+23,230
+94% +$1.05M 0.22% 118
2024
Q4
$1.15M Buy
24,815
+14,157
+133% +$640K 0.14% 162
2024
Q3
$482K Buy
10,658
+2,505
+31% +$119K 0.05% 263
2024
Q2
$402K Buy
+8,153
New +$332K 0.05% 260

Other funds holding TWST

IQ EQ Fund Management's TWST Position: Q1 2026 in Review

IQ EQ Fund Management reduced its Twist Bioscience (TWST) stake by 23% in Q1 2026, selling an estimated $3.9M and leaving 284,589 shares worth $13.5M. The position accounts for 1.03% of the portfolio, ranked #24.

IQ EQ Fund Management first reported a position in TWST in Q2 2024 and has held it in 8 quarters since. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • IQ EQ Fund Management held 284,589 shares of Twist Bioscience worth $13.5M as of Q1 2026.
  • IQ EQ Fund Management sold 86,963 Twist Bioscience shares in Q1 2026, an estimated $3.9M.
  • Twist Bioscience made up 1.03% of IQ EQ Fund Management's portfolio in Q1 2026, its #24 holding.
  • IQ EQ Fund Management first reported a position in Twist Bioscience in Q2 2024 and has held it in 8 quarters since.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.